Literature DB >> 7576318

The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.

M L Kalish1, A Baldwin, S Raktham, C Wasi, C C Luo, G Schochetman, T D Mastro, N Young, S Vanichseni, H Rübsamen-Waigmann.   

Abstract

OBJECTIVE: To genetically characterize HIV-1 strains in injecting drug users (IDU) in Bangkok, Thailand in 1994, and compare these with strains found earlier in Thai IDU; such information is essential for HIV-1 vaccine development and evaluation.
METHODS: Peripheral blood mononuclear cells were collected from 84 IDU attending 14 drug treatment clinics in Bangkok in 1994. DNA was amplified using a nested polymerase chain reaction (PCR) procedure and sequenced directly (without cloning) from the PCR products. The V3 and flanking regions (345 nucleotides) of the env gene were analyzed using a neighbor-joining tree.
RESULTS: Only one (1%) strain was a typical subtype B virus, 69 (82%) were genetically distinct subtype B' viruses (Thai B), and 14 (17%) were subtype E strains (Thai A). Persons with recently acquired infection were more likely to have subtype E viruses (P < 0.001) than those in our 1991 survey, who were more likely to have subtype B' viruses. Pairwise intra-subtype differences within subtypes E and B' were 5.3 and 4.3%, respectively, compared with 3.4 and 3.5% among strains collected in 1991 in Thailand.
CONCLUSION: The genetic diversity within subtypes B' and E in Thailand and the proportion of new infections due to subtype E viruses among Bangkok IDU are increasing significantly. These data highlight the importance of monitoring the molecular epidemiology of HIV-1 in populations being considered for HIV-1 vaccine trials.

Entities:  

Keywords:  Asia; Behavior; Developing Countries; Diseases; Drug Usage; Examinations And Diagnoses; Genetic Technics; Hiv; Hiv Infections; Iv Drug Users; Laboratory Examinations And Diagnoses; Laboratory Procedures; Research Report; Southeastern Asia; Thailand; Vaccines; Viral Diseases

Mesh:

Substances:

Year:  1995        PMID: 7576318     DOI: 10.1097/00002030-199508000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

1.  Identification of a novel HIV type 1 circulating recombinant form (CRF52_01B) in Southeast Asia.

Authors:  Yongjian Liu; Lin Li; Zuoyi Bao; Hanping Li; Daomin Zhuang; Siyang Liu; Xiaolin Wang; Tianyi Li; Lei Jia; Shaomin Yang; Jingyun Li
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-05       Impact factor: 2.205

2.  Near full-length genomic characterization of a HIV type 1 BC recombinant strain from Manipur, India.

Authors:  Roni Sarkar; Kamalesh Sarkar; N Brajachand Singh; Y Manihar Singh; Sekhar Chakrabarti
Journal:  Virus Genes       Date:  2012-06-19       Impact factor: 2.332

3.  Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.

Authors:  M Pope; S S Frankel; J R Mascola; A Trkola; F Isdell; D L Birx; D S Burke; D D Ho; J P Moore
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  Primate immunodeficiency virus classification and nomenclature: Review.

Authors:  Brian T Foley; Thomas Leitner; Dimitrios Paraskevis; Martine Peeters
Journal:  Infect Genet Evol       Date:  2016-10-24       Impact factor: 3.342

5.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

6.  Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer.

Authors:  Joseph P Nkolola; Christine A Bricault; Ann Cheung; Jennifer Shields; James Perry; James M Kovacs; Elena Giorgi; Margot van Winsen; Adrian Apetri; Els C M Brinkman-van der Linden; Bing Chen; Bette Korber; Michael S Seaman; Dan H Barouch
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

7.  CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Authors:  Awet Abraha; Immaculate L Nankya; Richard Gibson; Korey Demers; Denis M Tebit; Elizabeth Johnston; David Katzenstein; Asna Siddiqui; Carolina Herrera; Lucia Fischetti; Robin J Shattock; Eric J Arts
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa.

Authors:  F E McCutchan; A W Artenstein; E Sanders-Buell; M O Salminen; J K Carr; J R Mascola; X F Yu; K E Nelson; C Khamboonruang; D Schmitt; M P Kieny; J G McNeil; D S Burke
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 subtypes prevalence in central China.

Authors:  Fei Zhao; Zhe Wang; Wen-Jie Li
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.